TopNewsOn
U.S.

Scoop: White House drops Heidi Overton's FDA nomination

Alex Isenstadt·Axios·November 17, 2026
High · factual reporting (4 of 5)Outlet ratings by Media Bias/Fact Check

The White House is dropping Heidi Overton 's nomination to lead the Food and Drug Administration because of a lack of congressional support, Axios has learned. Why it matters: The decision means the Trump administration will have to find a new candidate to lead the FDA as HHS Secretary Robert F. Kennedy Jr. looks to advance his Make America Healthy Again agenda. "FDA nominee Heidi Overton lacks the support on the Hill to move forward with her confirmation," a senior administration official told Axios late Tuesday. The backstory: Overton, a physician and deputy director of the White House Domestic Policy Council, was nominated by Trump in August. Her nomination faced opposition from Democrats and skepticism from some Republican senators, including Sen. Bill Cassidy (R-La.), chair of the Senate's Health, Education, Labor and Pensions (HELP) Committee. Cassidy said he had "strong concerns" about Overton's role in the administration's efforts to change childhood vaccine recommendations, which he called "almost disqualifying." What they're saying: "We need to go in a new direction at FDA, and everybody fully supports Secretary Kennedy's vision to Make America Healthy Again and get back to a more populist and common-sense approach to health in America," the senior administration official said. What's next: The HELP committee had been scheduled to vote on Overton's nomination on Wednesday. The FDA has been led by acting Commissioner Kyle Diamantas since Marty Makary resigned in May. This is a breaking story and will be updated.

Read the full story at Axios →